S

Shandong Boan Biotechnology Co Ltd
HKEX:6955

Watchlist Manager
Shandong Boan Biotechnology Co Ltd
HKEX:6955
Watchlist
Price: 8.75 HKD 1.16% Market Closed
Market Cap: 5.4B HKD

Shandong Boan Biotechnology Co Ltd
Free Cash Flow

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Shandong Boan Biotechnology Co Ltd
Free Cash Flow Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Free Cash Flow CAGR 3Y CAGR 5Y CAGR 10Y
S
Shandong Boan Biotechnology Co Ltd
HKEX:6955
Free Cash Flow
-ÂĄ480.8m
CAGR 3-Years
6%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Free Cash Flow
-ÂĄ4.7B
CAGR 3-Years
24%
CAGR 5-Years
5%
CAGR 10-Years
N/A
Innovent Biologics Inc
HKEX:1801
Free Cash Flow
-ÂĄ355.1m
CAGR 3-Years
54%
CAGR 5-Years
28%
CAGR 10-Years
N/A
Akeso Inc
HKEX:9926
Free Cash Flow
-ÂĄ1.1B
CAGR 3-Years
13%
CAGR 5-Years
-26%
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Free Cash Flow
-ÂĄ532.3m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
S
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
HKEX:6990
Free Cash Flow
-ÂĄ510.9m
CAGR 3-Years
4%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Shandong Boan Biotechnology Co Ltd
Glance View

Market Cap
5B HKD
Industry
Biotechnology

Shandong Boan Biotechnology Co., Ltd. operates as a biopharmaceutical company that specializes in therapeutic antibody development, manufacturing and commercialization. The company is headquartered in Yantai, Shandong and currently employs 631 full-time employees. The company went IPO on 2022-12-30. The firm is engaged in the development, production and commercialisation of therapeutic antibodies, focusing on the therapeutic areas of oncology, metabolism, autoimmunology and ophthalmology. The firm has three main technology platforms: a fully human antibody transgenic mouse and phage display technology platform, a bispecific T-cell Engager technology platform, and an antibody drug coupling (ADC) technology platform. The firm operates mainly in the domestic Chinese market and overseas markets.

Intrinsic Value
8.36 HKD
Overvaluation 4%
Intrinsic Value
Price
S

See Also

What is Shandong Boan Biotechnology Co Ltd's Free Cash Flow?
Free Cash Flow
-480.8m CNY

Based on the financial report for Dec 31, 2024, Shandong Boan Biotechnology Co Ltd's Free Cash Flow amounts to -480.8m CNY.

What is Shandong Boan Biotechnology Co Ltd's Free Cash Flow growth rate?
Free Cash Flow CAGR 3Y
6%

Over the last year, the Free Cash Flow growth was -53%. The average annual Free Cash Flow growth rates for Shandong Boan Biotechnology Co Ltd have been 6% over the past three years .

Back to Top